UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Tag: neurodegenerative disorders

Augustine Therapeutics: Bridging the Valley of Death with VIB Discovery Sciences

This article is republished with kind permission from BioVox.

Augustine Therapeutics is one of VIB’s latest spinoffs, developing a first-in-class drug for Charcot-Marie-Tooth disease. The company recently announced a seed-funding round of €4.2 million, led by V-Bio Ventures. We spoke to several of the key persons in Augustine about how the startup is tackling the “Valley of Death”: the no-man’s-land between academia and industry where many potential therapies often fail.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive